BioSpark Roundtable: AI and Organ Chips to Replace Animal Studies: Are We Ready?

​Recent comments from FDA officials signal a groundbreaking shift in how we evaluate new medicines. According to Dr. Marty Makary, the agency is moving away from traditional animal testing—particularly with dogs and chimpanzees—and embracing advanced technologies such as AI-powered toxicity prediction and organ-on-a-chip systems. These innovations could dramatically accelerate drug development while addressing long-standing ethical concerns.

​At the same time, serious questions remain: How ready are we to make this transition? What challenges lie ahead in validation, regulation, and implementation?

​We invite select professionals in biotech, academia, and regulatory science to join us for an off-the-record, small-group roundtable discussion. Your insights are welcome as we examine the future of preclinical research at this pivotal moment.

​This is an in-person, closed-door event with limited capacity to ensure a high-quality and dynamic discussion.

​This event does not accept sponsorship and does not allow advertising.

​Please fill out the registration form carefully to be considered for attendance.